Trial intelligence / Profile preview

Shenfu Injection for post-cardiac arrest syndrome

ChiCTR-TRC-11001870Phase 4Completed

Sponsor
Beijing Chaoyang Hospital, Capital Medical University
Start
Dec 2011
Countries
1
01

Overview

Phase 4, randomised trial of shenfu injection in post-cardiac arrest syndrome (PCAS) (2 arms), sponsored by Beijing Chaoyang Hospital, Capital Medical University. Primary endpoint: Day 14 survival. Started Dec 2011; status: completed.

02

Drugs

shenfu injection
03

Conditions

post-cardiac arrest syndrome (PCAS)

Beyond the preview

Go deeper on ChiCTR-TRC-11001870.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-11001870.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call